The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Oxidative Stress in Cardiovascular Diseases
Open accessAbstract
Reactive oxygen species (ROS) are subcellular messengers in signal transductions pathways with both beneficial and deleterious roles. ROS are generated as a by-product of mitochondrial respiration or metabolism or by specific enzymes such as superoxide dismutases, glutathione peroxidase, catalase, peroxiredoxins, and myeloperoxidases. Under physiological conditions, the low levels of ROS production are equivalent to their detoxification, playing a major role in cellular signaling and function. In pathological situations, particularly atherosclerosis or hypertension, the release of ROS exceeds endogenous antioxidant capacity, leading to cell death. At cardiovascular levels, oxidative stress is highly implicated in myocardial infarction, ischemia/reperfusion, or heart failure. Here, we will first detail the physiological role of low ROS production in the heart and the vessels. Indeed, ROS are able to regulate multiple cardiovascular functions, such as cell proliferation, migration, and death. Second, we will investigate the implication of oxidative stress in cardiovascular diseases. Then, we will focus on ROS produced by NAPDH oxidase or during endothelial or mitochondrial dysfunction. Given the importance of oxidative stress at the cardiovascular level, antioxidant therapies could be a real benefit. In the last part of this review, we will detail the new therapeutic strategies potentially involved in cardiovascular protection and currently under study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 2×
“Several antioxidant defenses protect biological systems from ROS toxicity and include antioxidant enzymes with specific compartmentalization (superoxide dismutase (SOD), catalase, glutathione peroxidase, glutathione-S-transferase, and glucose-6-phosphatedehydrogenase) and non-enzymatic antioxidants (bilirubin, α-tocop…”
BackgroundEndothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · cited 1×
“Peroxynitrite is involved in atherosclerosis progression by inhibition of vasorelaxation, decrease in the beneficial effects of NO on platelet aggregation and vascular smooth muscle cell proliferation, and oxidation of DNA and lipids [48].”
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971 · cited 2×
“These isoforms also require different metallic cofactors and dimerization for their activity: the SOD1 dimer and the SOD3 tetramer require a bond to copper (Cu) and to zinc (Zn), hence they are named Cu-ZnSOD, whereas the SOD2 tetramer, also called MnSOD, uses manganese (Mn) as a cofactor [8].”
BackgroundBhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.010 · Cited by 1,655 · cited 1×
“Excessive ROS production occurs during mitochondrial dysfunction and induces irreversible damage to mitochondria, becoming significant contributors to the development of cardiovascular disease [53].”
BackgroundHomocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
(2005) · JAMA · doi:10.1001/jama.293.11.1338 · Cited by 1,209 · cited 1×
“Unfortunately, most of these clinical studies failed to show an improvement of vitamins supplementation at the cardiovascular level [57,83,84] or even reported an increased incidence of chronic congestive heart failure in humans [85,86].”
BackgroundLee, I.-M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.56 · Cited by 1,137
A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation
Erickson, J. R., Joiner, M.-L. A., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., Bartlett, R. K., Lowe, J. S., O'Donnell, S. E., Aykin-Burns, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.048 · Cited by 1,122
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Senoner, T., & Dichtl, W. (2019) · Nutrients · doi:10.3390/nu11092090 · Cited by 868
Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D., & Loscalzo, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116187 · Cited by 860
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., & Dikalov, S. I. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 737
Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4414 · Cited by 732
Ide, T., Tsutsui, H., Hayashidani, S., Kang, D., Suematsu, N., Nakamura, K.-I., Utsumi, H., Hamasaki, N., & Takeshita, A. (2001) · Circulation Research · doi:10.1161/01.res.88.5.529 · Cited by 731
Impact of Oxidative Stress on the Heart and Vasculature
Münzel, T., Camici, G. G., Maack, C., Bonetti, N. R., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.035 · Cited by 619
Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology
Kasai, S., Shimizu, S., Tatara, Y., Mimura, J., & Itoh, K. (2020) · Biomolecules · doi:10.3390/biom10020320 · Cited by 566
Dai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.232306 · Cited by 527
Scialò, F., Fernández-Ayala, D. J., & Sanz, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00428 · Cited by 517
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure
Li, J.-M., Gall, N. P., Grieve, D. J., Chen, M., & Shah, A. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000032031.30374.32 · Cited by 516
Kalyanaraman, B. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.014 · Cited by 502
Redox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 482
Mitochondrial ROS in myocardial ischemia reperfusion and remodeling
Bugger, H., & Pfeil, K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165768 · Cited by 460
Anderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn280 · Cited by 377
Park, T.-J., Park, J. H., Lee, G. S., Lee, J.-Y., Shin, J. H., Kim, M. W., Kim, Y. S., Kim, J.-Y., Oh, K.-J., Han, B.-S., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2061-8 · Cited by 364
Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., Shimamoto, K., & Horio, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090266 · Cited by 358
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution
Niemann, B., Rohrbach, S., Miller, M. R., Newby, D. E., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.043 · Cited by 353
Sepasi Tehrani, H., & Moosavi-Movahedi, A. A. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.03.001 · Cited by 290
Ni, R., Cao, T., Xiong, S., Ma, J., Fan, G.-C., Lacefield, J. C., Lu, Y., Tissier, S. L., & Peng, T. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.013 · Cited by 288
Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase
Stroes, E. S. G., van Faassen, E. E., Yo, M., Martasek, P., Boer, P., Govers, R., & Rabelink, T. J. (2000) · Circulation Research · doi:10.1161/01.res.86.11.1129 · Cited by 285 · cited 1×
“For instance, folic acid improves endothelial function in vitro by reducing oxidative stress [61] and folic acid and vitamin B (12) supplementation on isoprenaline; induced myocardial infarction in hyperhomocysteinemic rats decreases oxidative stress and improve cardiac function, such as heart rate, ST segment elevati…”
BackgroundScioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281 · cited 2×
“Endothelial dysfunction is defined as a decreased production and availability of NO, with or without an imbalance between endothelium-derived contracting and relaxing factors associated with a pro-inflammatory and prothrombotic status [46].”
BackgroundThe therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway
Farkhondeh, T., Folgado, S. L., Pourbagher-Shahri, A. M., Ashrafizadeh, M., & Samarghandian, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110234 · Cited by 273
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., García-Conesa, M. T., Tomás-Barberán, F. A., & Espín, J. C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.030 · Cited by 259
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Basic Biology of Oxidative Stress and the Cardiovascular System
Sack, M. N., Fyhrquist, F. Y., Saijonmaa, O. J., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.034 · Cited by 240
Dikalov, S., Itani, H., Richmond, B., Arslanbaeva, L., Vergeade, A., Rahman, S. M. J., Boutaud, O., Blackwell, T., Massion, P. P., Harrison, D. G., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00595.2018 · Cited by 212
Peroxisomal Hydrogen Peroxide Metabolism and Signaling in Health and Disease
Lismont, C., Revenco, I., & Fransen, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153673 · Cited by 203
Dyck, G. J. B., Raj, P., Zieroth, S., Dyck, J. R. B., & Ezekowitz, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040904 · Cited by 200
Wallert, M., Ziegler, M., Wang, X., Maluenda, A., Xu, X., Yap, M. L., Witt, R., Giles, C., Kluge, S., Hortmann, M., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101292 · Cited by 200
Banez, M. J., Geluz, M. I., Chandra, A., Hamdan, T., Biswas, O. S., Bryan, N. S., & Von Schwarz, E. R. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.03.002 · Cited by 200
Oxidative Stress and Sarcomeric Proteins
Steinberg, S. F. (2013) · Circulation Research · doi:10.1161/circresaha.111.300496 · Cited by 195
Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
Umar, S., & van der Laarse, A. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0219-x · Cited by 182
Serpillon, S., Floyd, B. C., Gupte, R. S., George, S., Kozicky, M., Neito, V., Recchia, F., Stanley, W., Wolin, M. S., & Gupte, S. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01142.2008 · Cited by 179
Dai, D.-F., Hsieh, E. J., Liu, Y., Chen, T., Beyer, R. P., Chin, M. T., MacCoss, M. J., & Rabinovitch, P. S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr274 · Cited by 178 · cited 1×
“An increase in ROS production has already been described in several cardiac diseases such as myocardial fibrosis [29], type 2 diabetes [30,31], metabolic syndrome [32–36], cardiac hypertrophy [9,37,38], heart failure [39], and myocardial infarction [40,41].”
BackgroundModelling mitochondrial ROS production by the respiratory chain
Mazat, J.-P., Devin, A., & Ransac, S. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03381-1 · Cited by 176
Obesity Induces Signs of Premature Cardiac Aging in Younger Patients
Niemann, B., Chen, Y., Teschner, M., Li, L., Silber, R.-E., & Rohrbach, S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.040 · Cited by 175
Mitochondrial Redox Cycling of Mitoquinone Leads to Superoxide Production and Cellular Apoptosis
Doughan, A. K., & Dikalov, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1693 · Cited by 172
The role of reactive oxygen species in myocardial redox signaling and regulation
Moris, D., Spartalis, M., Tzatzaki, E., Spartalis, E., Karachaliou, G.-S., Triantafyllis, A. S., Karaolanis, G. I., Tsilimigras, D. I., & Theocharis, S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.17 · Cited by 164
Rao, V. A., Klein, S. R., Bonar, S. J., Zielonka, J., Mizuno, N., Dickey, J. S., Keller, P. W., Joseph, J., Kalyanaraman, B., & Shacter, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133579 · Cited by 139
Agarwal, B., Campen, M. J., Channell, M. M., Wherry, S. J., Varamini, B., Davis, J. G., Baur, J. A., & Smoliga, J. M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.027 · Cited by 137
Sverdlov, A. L., Elezaby, A., Qin, F., Behring, J. B., Luptak, I., Calamaras, T. D., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002555 · Cited by 137
Oxidative stress and endothelial dysfunction: Therapeutic implications
Gori, T., & Münzel, T. F. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.543920 · Cited by 133
Oxidative Stress and Cardiac Remodeling: An Updated Edge
Rababa’h, A. M., Guillory, A. N., Mustafa, R., & Hijjawi, T. B. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180111145207 · Cited by 132
van der Made, S. M., Plat, J., & Mensink, R. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118393 · Cited by 131
Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., & Das, D. K. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.09.028 · Cited by 129
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Fortuño, A., San José, G., Moreno, M. U., Beloqui, O., Díez, J., & Zalba, G. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0751 · Cited by 128
Straßburger, M., Bloch, W., Sulyok, S., Schüller, J., Keist, A. F., Schmidt, A., Wenk, J., Peters, T., Wlaschek, M., & Krieg, T. M. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.009 · Cited by 125
Jeong, E., Chung, J., Liu, H., Go, Y., Gladstein, S., Farzaneh‐Far, A., Lewandowski, E. D., & Dudley, S. C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003046 · Cited by 119
Olesen, J., Gliemann, L., Biensø, R., Schmidt, J., Hellsten, Y., & Pilegaard, H. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270256 · Cited by 119
Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: From contractility to remodeling
Hammond, J., & Balligand, J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.029 · Cited by 115
Cianciolo, G., Pascalis, A. D., Lullo, L. D., Ronco, C., Zannini, C., & Manna, G. L. (2017) · Cardiorenal Medicine · doi:10.1159/000471813 · Cited by 115
Agouni, A., Lagrue-Lak-Hal, A.-H., Mostefai, H. A., Tesse, A., Mulder, P. G. H., Rouet, P., Desmoulin, F., Heymes, C., Martínez, M. C., & Andriantsitohaina, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005557 · Cited by 111
Imamura, H., Yamaguchi, T., Nagayama, D., Saiki, A., Shirai, K., & Tatsuno, I. (2017) · International Heart Journal · doi:10.1536/ihj.16-373 · Cited by 105
Sung, M. M., Das, S. K., Levasseur, J., Byrne, N. J., Fung, D., Kim, T. T., Masson, G., Boisvenue, J., Soltys, C.-L., Oudit, G. Y., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001677 · Cited by 102 · cited 1×
“In mice subjected to transverse aortic constriction to induce heart failure, resveratrol significantly increased survival and decreased cardiac fibrosis and markers for hypertrophy and extracellular matrix remodeling and improved diastolic function [72].”
BackgroundWeng, X., Yu, L., Liang, P., Li, L., Dai, X. J., Zhou, B., Wu, X., Xu, H., Fang, M., Chen, Q., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.010 · Cited by 101
Lancel, S., Qin, F., Lennon, S. L., Zhang, J., Tong, X., Mazzini, M. J., Kang, Y. J., Siwik, D. A., Cohen, R. A., & Colucci, W. S. (2010) · Circulation Research · doi:10.1161/circresaha.110.217570 · Cited by 100
NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis
Santillo, M., Colantuoni, A., Mondola, P., Guida, B., & Damiano, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00194 · Cited by 95 · cited 2×
“, NOX1, NOX2, NOX4, and NOX5) are regulated by AngII that increases the blood pressure and NOX-dependent ROS, which in turn, activate the AngII receptor type 1 (AT-1) with an auto amplificatory effect [42].”
BackgroundFarhangi, M. A., Nameni, G., Hajiluian, G., & Mesgari-Abbasi, M. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0597-z · Cited by 81
Hermida, N., Michel, L. Y. M., Esfahani, H., Dubois‐Deruy, E., Hammond, J., Bouzin, C., Markl, A., Colin, H., Steenbergen, A. V., de Meester, C., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx366 · Cited by 81
Self-citationBeyond ROS clearance: Peroxiredoxins in stress signaling and aging
Detienne, G., Haes, W. D., Mergan, L., Edwards, S. L., Temmerman, L., & Bael, S. V. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.03.005 · Cited by 77
Macedo, R. C., Vieira, A., Marin, D. P., & Otton, R. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.033 · Cited by 70
Mankowski, R. T., You, L., Buford, T. W., Leeuwenburgh, C., Manini, T. M., Schneider, S., Qiu, P., & Anton, S. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110821 · Cited by 70
Mollnau, H., Oelze, M. W., August, M., Wendt, M., Daiber, A., Schulz, E., Baldus, S. E., Kleschyov, A. L., Materne, A., Wenzel, P., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190673.41925.9b · Cited by 68
Pokrzywinski, K. L., Biel, T. G., Kryndushkin, D. S., & Rao, V. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168283 · Cited by 68
Hariri, M. A., Zibara, K., Farhat, W., Hashem, Y., Soudani, N., Ibrahim, F. A., Hamade, E., Zeidan, A., Husari, A. W., & Kobeissy, F. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00397 · Cited by 66
Merabet, N., Bellien, J., Glevarec, E., Nicol, L., Lucas, D., Remy-Jouet, I., Bounoure, F., Dreano, Y., Wecker, D., Thuillez, C., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.015 · Cited by 63
Kim, S., Song, J., Erñst, P., Latimer, M. N., Ha, C., Goh, K. Y., Ma, W., Namakkal-Soorappan, R. N., Zhang, J., Liu, M., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00617.2019 · Cited by 60
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
Dubois‐Deruy, E., Cuvelliez, M., Fiedler, J., Charrier, H., Mulder, P. G. H., Hebbar, E., Pfanne, A., Beseme, O., Chwastyniak, M., Amouyel, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15011-6 · Cited by 57
Self-citationProteomic Analysis of Left Ventricular Remodeling in an Experimental Model of Heart Failure
Cieniewski‐Bernard, C., Mulder, P. G. H., Henry, J., Drobecq, H., Dubois‐Deruy, E., Pottiez, G., Thuillez, C., Amouyel, P., Richard, V. J., & Pinet, F. (2008) · Journal of Proteome Research · doi:10.1021/pr800409u · Cited by 54
Self-citationIbarrola, J., Arrieta, V., Sádaba, R., Martínez‐Martínez, E., García-Peña, A., Álvarez, V., Fernández‐Celis, A., Gainza, A., Santamaría, E., Fernández‐Irigoyen, J., et al. (2018) · Clinical Science · doi:10.1042/cs20171389 · Cited by 48
Jiménez‐González, S., Marín‐Royo, G., Jurado-López, R., Bartolomé, M. V., Romero‐Miranda, A., Luaces, M., Islas, F., Nieto, M. L., Martínez‐Martínez, E., & Cachofeiro, V. (2020) · Cells · doi:10.3390/cells9020451 · Cited by 42
Targeting mitochondrial dysfunction in the treatment of heart failure
Sabbah, H. N. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1249466 · Cited by 35
Huang, J.-P., Hsu, S.-C., Li, D.-E., Chen, K.-H., Kuo, C.-Y., & Hung, L.-M. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000621 · Cited by 33
Li, X., Lin, Y., Wang, S., Zhou, S., Ju, J., Wang, X., Chen, Y., & Xia, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016862 · Cited by 32
CONSTITUTIVE NITRIC OXIDE SYNTHASES IN THE HEART FROM HYPERTROPHY TO FAILURE
Loyer, X., Heymes, C., & Samuel, J. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04901.x · Cited by 30
Ma, L., Wang, K., Shang, J., Cao, C., Zhen, P., Liu, X., Wang, W., Zhang, H., Yunhui, D., & Liu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104788 · Cited by 20
In vitro and in vivo cardioprotective and metabolic efficacy of vitamin E TPGS/Apelin
Goto, P. L., Cinato, M., Merachli, F., Павлюк, Б. В., Jimenez, T., Marsal, D. J., Todua, N., Loi, H., Santin, Y., Cassel, S., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.12.001 · Cited by 17
Kuzuya, K., Ichihara, S., Suzuki, Y., Inoue, C., Ichihara, G., Kurimoto, S., & Oikawa, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192624 · Cited by 7
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat
Villalpando-Rodriguez, G. E., & Gibson, S. B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9912436 · Cited by 491
Correia, A. S., Cardoso, A., & Vale, N. (2023) · Antioxidants · doi:10.3390/antiox12020470 · Cited by 340
Identification and molecular docking of antioxidant peptides from hemp seed protein hydrolysates
Gao, J., Li, T., Chen, D., Gu, H., & Mao, X. (2021) · LWT · doi:10.1016/j.lwt.2021.111453 · Cited by 106
Metadata
- Authors
- Dubois-Deruy, E., Peugnet, V., Turkieh, A., & Pinet, F.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2020-09-14
- Volume
- 9
- Issue
- 9
- Pages
- 864
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3084965219
- Cited by
- 646
- References
- 94
- FWCI
- 30.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.